Cargando…
Mesoamerican Nephropathy (MeN): What We Know so Far
In 2002, a report from El Salvador described a high incidence of chronic kidney disease (CKD) of unknown cause, mostly in young males from specific coastal areas. Similar situations were observed along the Pacific Ocean coastline of other Central American countries and southern Mexico (Mesoamerica)....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588276/ https://www.ncbi.nlm.nih.gov/pubmed/33116757 http://dx.doi.org/10.2147/IJNRD.S270709 |
_version_ | 1783600340367572992 |
---|---|
author | Sanchez Polo, Vicente Garcia-Trabanino, Ramon Rodriguez, Guillermo Madero, Magdalena |
author_facet | Sanchez Polo, Vicente Garcia-Trabanino, Ramon Rodriguez, Guillermo Madero, Magdalena |
author_sort | Sanchez Polo, Vicente |
collection | PubMed |
description | In 2002, a report from El Salvador described a high incidence of chronic kidney disease (CKD) of unknown cause, mostly in young males from specific coastal areas. Similar situations were observed along the Pacific Ocean coastline of other Central American countries and southern Mexico (Mesoamerica). This new form of CKD has been denominated Mesoamerican endemic nephropathy (MeN). The typical presentation of MeN is a young male from an endemic area with a family history of CKD, low eGFR, high serum creatinine, low level of albuminuria, hypokalemia, hyperuricemia, and urine urate crystals. Kidney biopsy demonstrating tubulointerstitial nephritis remains the gold standard for diagnosis but is available only for a minority. Commonly proposed causes include thermal stress/dehydration and/or exposure to environmental pollutants. However, likely, a third factor, which could be genetic or epigenetic, could contribute to the cause and development of the disease, along with social determinants. Currently, preventive measures focus on minimizing workers exposure to thermal stress/dehydration. There are many research opportunities and priorities should include clinical trials to evaluate the efficacy and safety of the current treatment protocols, along with etiological and genetic studies, and the development of kidney disease data systems. Although there is scant and controversial literature with regard s to the etiology, diagnosis and management of the disease, our aim is to provide the reader a vision of the disease based on our experience. |
format | Online Article Text |
id | pubmed-7588276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75882762020-10-27 Mesoamerican Nephropathy (MeN): What We Know so Far Sanchez Polo, Vicente Garcia-Trabanino, Ramon Rodriguez, Guillermo Madero, Magdalena Int J Nephrol Renovasc Dis Review In 2002, a report from El Salvador described a high incidence of chronic kidney disease (CKD) of unknown cause, mostly in young males from specific coastal areas. Similar situations were observed along the Pacific Ocean coastline of other Central American countries and southern Mexico (Mesoamerica). This new form of CKD has been denominated Mesoamerican endemic nephropathy (MeN). The typical presentation of MeN is a young male from an endemic area with a family history of CKD, low eGFR, high serum creatinine, low level of albuminuria, hypokalemia, hyperuricemia, and urine urate crystals. Kidney biopsy demonstrating tubulointerstitial nephritis remains the gold standard for diagnosis but is available only for a minority. Commonly proposed causes include thermal stress/dehydration and/or exposure to environmental pollutants. However, likely, a third factor, which could be genetic or epigenetic, could contribute to the cause and development of the disease, along with social determinants. Currently, preventive measures focus on minimizing workers exposure to thermal stress/dehydration. There are many research opportunities and priorities should include clinical trials to evaluate the efficacy and safety of the current treatment protocols, along with etiological and genetic studies, and the development of kidney disease data systems. Although there is scant and controversial literature with regard s to the etiology, diagnosis and management of the disease, our aim is to provide the reader a vision of the disease based on our experience. Dove 2020-10-22 /pmc/articles/PMC7588276/ /pubmed/33116757 http://dx.doi.org/10.2147/IJNRD.S270709 Text en © 2020 Sanchez Polo et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Sanchez Polo, Vicente Garcia-Trabanino, Ramon Rodriguez, Guillermo Madero, Magdalena Mesoamerican Nephropathy (MeN): What We Know so Far |
title | Mesoamerican Nephropathy (MeN): What We Know so Far |
title_full | Mesoamerican Nephropathy (MeN): What We Know so Far |
title_fullStr | Mesoamerican Nephropathy (MeN): What We Know so Far |
title_full_unstemmed | Mesoamerican Nephropathy (MeN): What We Know so Far |
title_short | Mesoamerican Nephropathy (MeN): What We Know so Far |
title_sort | mesoamerican nephropathy (men): what we know so far |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588276/ https://www.ncbi.nlm.nih.gov/pubmed/33116757 http://dx.doi.org/10.2147/IJNRD.S270709 |
work_keys_str_mv | AT sanchezpolovicente mesoamericannephropathymenwhatweknowsofar AT garciatrabaninoramon mesoamericannephropathymenwhatweknowsofar AT rodriguezguillermo mesoamericannephropathymenwhatweknowsofar AT maderomagdalena mesoamericannephropathymenwhatweknowsofar |